Found 4 matching trials
Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome
PHASE2This is a multicenter, single arm open label Phase 2b Study of oral ezatios...
Location
Bay Area Cancer Research Group
Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome
PHASE2Study TLK199.2107 is a multicenter, single arm, open-label Phase 2 study of...
Location
Loyola University
Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
PHASE1This is an open label, multicenter Phase 1 dose escalation study evaluating...
Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer
PHASE2TLK199.2102 was a multicenter Phase 2 randomized study to determine the eff...
Location
Central Hematology Oncology Medical Group